Company / Free Cash Flow
BioAge Labs, Inc. Free Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$82.3M
FY2025
5-year range
-$82.3M / -$37.5M
FY2023-FY2025
Trend
-58.7%
vs FY2024
Sector context
#98 of 194
Health Care
What the data says
At -$82M, BioAge Labs, Inc.'s free cash flow ranks #98 of 194 in the Health Care sector. Declined from -$38M to -$82M over the past 2 years.
Based on SEC 10-K filings.
-$82M in FY2025.
Declined from -$38M to -$82M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#98 of 194 in Health CareTop 51% of 194This company -$82.3M Sector average $470.6M
▼
-117.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 58.7% year-over-year.
- Ranks #98 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$82.3M | -58.7% |
| FY2024 | -$51.9M | -38.3% |
| FY2023 | -$37.5M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026